МОНОГРАФИЯ Гепатит и последствия гепатита. Майер К.-П (в word). Гепатит и последствия гепатита Практич рук. Пер с нем. Под ред. А. А. Шепулина. М. Гэотар медицина, 1999. 432 с
 Скачать 6.25 Mb.
|
|
t Tagger, A Dal Canton, N Bizzaro, G Taganello, A Ruol Antibody to hepatitis С virus and liver disease in volunteer blood donors Ann intern Med 114(1991)1010-1012 Alberti, A , G Morsica, L Chemello, D Cavalletto, F Noven ta, P Pontisso, A Ruol Hepatitis С viraemia and liver disease in symptom-free individuals with anti-HCV Lancet (1992) 340697-98 Alward, W L M , В J McMahon, D В Hall, W L Heyward, D P Francis, T R Bender The long-term serological course of asymptomatic hepatitis В virus carriers and the development of primary hepatocellular carcinoma J infect Dis 151(1985)604-609 Anco, S , M Rizzetto, A Zanetti, S Diana, M Aronone, G Pastore Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers Lancet 1985/11, 356-358 Bnllanti, S , M Foh, S Gaiani, С Masci M Miglioh, L Barbara Persistent hepatitis С viraemia without hvei disease Lancet 341 (1993) 464 465 Chang, М -Н , L -Y Hwang, Н -С Hsu, С-Y Lee, R Р Beas-ley Prospective study of asymptomatic HBsAg earner children infected in the perinatal period clinical and liver histologic studies Hepatology 8 (1988) 374-377 Farci, P, A Smedile, С Lavanni, P Plantino, О Cnvelli, N Caporaso, M Toti, F Bonino, M Rizzetto Delta hepatitis in inapparent earners of hepatitis В surface antigen Gastroente-rology 85 (1983) 669-673 Fattovich, G , A Tagger, L Brollo, G Giustina, P Pontisso, G Realdi, A Albert, A Ruol Hepatitis С virus infection in chronic hepatitis В virus carriers J infect Dis 163(1991)400-402 Hoofnagle, J H , D A Shafntz, H Popper Chronic type В hepatitis and the "healthy" HBsAg carrier state Hepatology 7 (1987) 758-763 Koflf, R S Management of the hepatitis В surface antigen (HBsAg) carrier Semin Liver Dis 1 (1981) 33-43 Luo, К X , R Zhou, С He, Z S Liang, S Jiang Hepatitis В virus DNA in sera of virus carriers positive exclusively for antibodies to the hepatitis В core antigen J med Virol 35 (1991) 55-59 Rizzetto, M , G Verme, S Recchia, F Bonino, P Farci, S Anco, R Calzia, A Picciotto, M Colombo, H Popper Chronic hepatitis in carriers of hepatitis В surface antigen, with intrahepatic expression of the delta antigen Ann intern Med 98 (1983)437-441 Sakuma, К , T Takahara, К Okuda, F Tsuda, M Mayumi Prognosis of hepatitis В virus surface antigen carriers in relation to routine liver function tests a prospective study Gastroenterology 83 (1982) 114-117 Scheiermann, N , В Kuwert, J Remy Hepatitis-B-Virus-Durchseuchung des medizinischen Personals in Arzt- praxen Dtsch med Wschr 110 (1985)180-182 Tabor, E , L В Seeff, R J Gerety Chronic non-A, non-B hepatitis carrier state New Engl J Med 302 (1980) 140-143 Villa, E, T Barchi, A Gnsendi, S Bellentam, L Rubbiani, I Ferretti, M Palma, F Manenti Susceptibility of chronic symptomless HBsAg earners to ethanol-induced hepatic damage Lancet 1982/11,1243-1244 9 ВИРУСНЫЙ ГЕПАТИТ В ОТДЕЛЕНИЯХ ГЕМОДИАЛИЗА Bansky, G , Р J Grob, H I Joller-Jemelka, К Zaruba, H lsehn, H J Gloor Non-A-non-B-Hepatitis bei chro-nisch ha-modialysierten Patienten Schweiz med Wschr 114(1984)1423-1427 Benhamou, E , A M Courouce, A Laplanche, P Jungers, J F Tron, J Crossnier Long-term results of hepatitis В vaccination in patients on dialysis New Engl J Med 314(1986)1110-1111 Bramwell, S P, J D Bnggs, J Stewart, M A Watson, D J Tsakins, E С Follett, D L McWhinme, D N H Hamilton Dinitrochlorobenzene skin testing predicts response to hepatitis В vaccine in dialysis patients Lancet I985/U412-I4I5 Calabrese, G , G Vagelli, R Guaschino, M Gonella Transmission of anti-HCV within the household of hae- modialysis patients Lancet 338 (1991) 1466 (letter) Desmyter, J , G de Groote, J Colaert, M Reynders, E E Reennk Brongers, P N Lene, P J Dees, H W Reesink Efficacy of heat-inactivated hepatitis В vaccine in haemodialysis patients and staff Lancet 1983/11, 1323-1327 Etspuler, W , L Wagner, G Zouiek, F Deinhardt Aktive Schutzimpfung von Dialysepatienten gegen Hepatitis В Munch, med Wschr 129 (1987)493-495 Favero, M S , N Deane, R T Leger, A E Sosin Effect of multiple use of dialyzers on hepatitis В incidence in patients and staff J Amer med Ass 245(1981)166-167 Gilli, P,M Moretti, S Sofntti, N Marchi, F Malacarne, P L Bedani Non-A, non-B hepatitis and anti-HCV antibodies in dialysis patients Internal J art if Org 13 (1990) 737-741 Hayashi, J , К Nakashima, W Kajiyama, A Noguchi, M Morofuji, Y Maeda, S Kashiwagi Prevalence of antibody to hepatitis С virus in hemodialysis patients Amer J Epide-miol 134(1991) 651-656 Jilg, W , M Schmidt, В Weinel, Th Kinder, H Brass, J Bommer, R Muller, В Schulte, A Schwarzbeck, F Deinhardt Immunogenicity of recombinant hepatitis В vaccine in dialysis patients J Hepatol 3 (1986) 190-195 Koreth, R,0 Stone M Mousa u Mitarb The pursuit of hepatitis in dialysis units Amer J Nephrol 4(1984) 222-226 Najem, G R , D В Louna, I S Thmd, M A Lavenhar, D J Gocke, S E Baskin, A M Miller, H J Frankel, J Notkin, M G Jacobs, В Weiner Control of hepatitis В infection The role of surveillance and isolation in hemodialysis center J Amer med Ass 245 (1981) 153-157 Parfey, P, D Farge, R Forbes Chronic hepatitis in end-stage renal disease comparison of HBsAg-negative and positive patients Kidney Int 28 (1985) 959-967 Simon, N Prevention ofnon-A, non-B hepatitis in haemodialysis patients by hepatitis В immunoglobulin Lancet 1984/11, 1047 (letter) Seaworth, В J , L E Garrett, W W Stead, J D Hamilton Non-A, non-B hepatitis and chronic dialysis - another dilemma Amer J Nephrol 4 (1984) 235-239 Shustermann, N , I Singer Infectious hepatitis in dialysis patients Amer J Kidney Dis 1987/1X447-450 Steketee, R W , M E Ziarmk, J P Davis Seroresponse to hepatitis В vaccine in patients and staff of renal dialysis centers in Wisconsin Amer J Epidemiol 127 (1988) 772-782 Stevens, С Е , Н J Alter, Р Е Taylor, Е A Zang, Е J Har-ley, W Szmuness Hepatitis В vaccine m patients receiving hemodialysis immunogenicity and efficacy New Engl J Med 311(1984)496-501 Stevens, С E , W Szmuness, A 1 Goodman, S A Weseley, M Fotmo Hepatitis В vaccine Immune responses in haemodialysis patients Lancet 1980/11,1211-1214 Szmuness, W , С E Stevens, E J Harley, E A Zang, H J Alter, P E Taylor, D de Vera, GTS Chen, A Kellner Hepatitis В vaccine in medical staff of hemodialysis units efficacy and subtype cross-protection New Engl J Med 307 (1982)1481-1486 10 ДРУГИЕ ВИРУСНЫЕ ГЕПАТИТЫ Marne, T , A T J McDonald, P E Conen, S F J Boudreau Herpes simplex hepatitis - Use of lmmunoperoxi-dase to demonstrate the viral antigen in hepatocytes Gastroenterology 82 (1982) 71-76 Martini, G A Hepatitis m infectious mononucleosis In L Bianchi, W Gerok, К Sickmger, G A Stalder Virus and the Liver MTP-Press, 1980 (pp 305-310) Phillips, M J , L M Blendis, S Poucell.J Patterson, M Petnc, E Roberts, G A Levi, R Supenna, P D Greig, R Came-ron, В Langer, R H Purcell Syncytial giant-cell hepatitis Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxo viral features New Engl J Med 324 (1991)455-460 11 ЗАБОЛЕВАНИЯ С КЛИНИЧЕСКОЙ КАРТИНОЙ, ПОХОЖЕЙ НА ГЕПАТИТ Biour, М , R Poupon, J D Grange, О Chazoulleres, V G Levy, F Bodm, G Cheymol Hepatotoxicite des medicaments Mise a jour du fichier bibhographique des attemtes hepatiques et des medicaments respon-sables Gastroenterol Clm Biol 16 (1992)64-88 Black, M Acetaminophen Hepatotoxicity Gastroenterology 78 (1980) 382-392 Bode, J Ch Arzneimittelschaden der Leber Dtsch med Wschr 110 (1985)1543-1548 Davis, M Protective agents for acetaminophen overdose Sc-mm Liv Dis 6 (1986)138-147 Dolle, W Leberschadigung durch Arzneimittel In H Hornbo-stel, W Kaufmann. W Siegenthaler Innere Medizm m Praxis und Khnik, 3 AufL, Bd IV Thieme, Stuttgart 1986 (S 15 282) Farrell, G , D Prendergast, M Murray Halothane hepatitis, detection of a constitutional susceptibility factor New Engl J Med 313 (1985)1310-1314 Kimura, H , К Akamatsu, H Sakaue, M Nogawa, Y Ohta Fulminant hepatitis induced by cimetidine J Gastroenterol Hepatol 3 (1988) 223-226 Lee, M G , В Hanchard, N P Williams Drug-induced acute hver disease Postgrad, med J 65 (1989) 367-370 Maier, К -P Die Behandlung der akuten Hepatitis Verh dtsch Ges inn Med 90(1984)191-197 Mitchell, M С , St Schenker, G R Avant, К V Speeg Cimetidine protects against acetaminophen hepatotoxicity in rats Gastroenterology 81 (1981) 1052-1060 Moore, D H , G D Benson Prolonged halothane hepatitis, prompt resolution of severe lesion with corticosteroid therapy Dig Dis Sci 31 (1986) 1269-1272 Prescott, F , R N llhngworth, J A Cntchtey, M J Stewart, R D Adam, A T Proudfoot Intravenous N-acetyl- cysteine the treatment of choice for paracetamol poisoning Bnt med J 1979/111,1097-1100 Zimmerman, H J Drug-induced liver disease In Taylor, M В , J L Gollan, M A Peppercorn, M L Steer, MM Wolfe (eds ) Gastrointestinal Emergencies Williams & Wil-kms Baltimore, 1992 (p 290) 12-3 ХРОНИЧЕСКИЙ ВИРУСНЫЙ ГЕПАТИТ В Blum, Н Е , Т J Liang, J R Wands Cloning and complete nucleotide sequence analysis of extra-chromosomal hepatitis В virus (HBV) variant DNA from the liver of a patient serolo-gically immune to HBV infection Hepatology 10(1989) 641 (abstract) Bonmo, F,F Rosma, M Rizzetto, R Rizzi, E Chiaberge, R Tardamco, Fa Callea, G Verme Chronic hepatitis in HBsAg earners with serum HBV-DNA and anti-HBe Gastroenterology 90 (1986) 1268-73 Brook, M G , J A McDonald, P Karayiannis, L Caruso, G Forster, Z R W Harris, H С Thomas Randomized controlled trial of interferon alfa 2A (Roferon-A) for the treatment of chronic hepatitis В virus (HBV) infection factors that influence response Gut 30 (1989) 1116-1122 Brunetto, M R , F Liven, G Rocca, D Cnscuolo, E Chiaberge, M Capalbo, E David, G Verme, F Bonmo Natural course and response to interferon of chronic hepatitis В accompanied by antibody to hepatitis В e antigen Hepatology 10 (1989) 198-202 Carman, W F , S Hadziyannis, M J McGarvey, M R Jacyna, P Karayiannis, A Makns Mutation preventing formation of hepatitis Be antigen in patients with chronic hepatitis В infection Lancet 1989/11, 588-590 Carman, WF, MR Jacyna, P Karayiannis, S Hadziyannis, M J McGarvey, A Makns, H С Thomas Occurrence of a novel translational stop codon m the pre-core/core gene of HBV in anti-HBe positive patients with chronic hepatitis and persistent HBV replication Hepatology 10 (1989) 582 (abstract) Carreno, V , I Mora Combination ofrecombmant interferons alpha and gamma m treatment of chronic hepatitis В Lancet 1987/11, 1086 (letter) Carreno, V, A Moreno, F Gahana, F J Bartolome Alpha-and gamma-mterferon versus alpha-mterferon alone in chronic hepatitis В A randomized controlled study J Hepatol 17 (1993) 1321-1325 Caselmann, W H,J Eisenburg, P H Hofschneider, R Koshy P- and g-Interferon in chronic active hepatitis B, a pilot trial of short-term combination therapy Gastroenterology 96 (1989) 449-455 Davis, G L, J H Hoofnagle Interferon in viral hepatitis role in pathogenesis and treatment Hepatology 6 (1986) 1038-1041 DeJongh, F E,H L A Janssen, R A de Man, W С H Hop, S W Schalm, M van Blankenstein Survival and prognostic indicators in hepatitis В surface antigen-positive cirrhosis of the liver Gastroenterology 103 (1992) 1630-1635 Editorial A Trial Group of the European Association for the Study of the Liver Steroids in chronic B-Hepatitis A randomized, doubleblmd, multinational trial on the effect of low-dose, long-term treatment on survival Liver 6 (1986) 227-232 Fattovich, G , L Brollo, S Boscaro, P Pontisso, G Gmstma, С Cnscuolo, D Maladorno, A Albert, G Real-di, A Ruol Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis В J Hepatol 9 (1989) 331-337 Fattovich, G , L Brollo, P Pontisso, E Pornaro, M Rugge, A Albert, G Realdi Levamisole therapy in chronic type В hepatitis, results of a double blind randomized trial Gastroenterology 91 (1986) 692-696 Fattovich, G , L Brollo, S Boscaro, P Pontisso, G Gmstma, D Cnscuolo, D Maladorno, A Albert, G Realdi, A Ruol Long-term effect of low dose recombinant interferon therapy in patients with chronic hepatitis В J Hepatol 9 (1989) 331-337 Fattovich, G, P Farci, M Rugge, L Brollo, A Mandas, P Pontisso, G Gmstma, M E Lai, F Belussi, G Busatto, A Balestnen, A Ruol, A Albert A randomized controlled trial of lymphoblastoid mterferon-alpha in patients with chronic hepatitis В lacking HBeAg Hepatology 15 (1992) 584-589 Fattovich, G , G Gmstma, L Brollo, M Guido, P Pontisso, F Noventa, A Albert Therapy for chronic hepatitis with lymphoblastoid mterferon-alpha and levamisole Hepatology 16 (1992) 1115-1119 Femman, S V , В Berns, R Sooknanan, В Fernandes, S Bojarski Effects of mterferon-alpha therapy on serum and hver HBV-DNA in patients with chronic hepatitis В Dig Disc Sci 37 (1992)1477-1482 Foster, G R , R D Goldin, A Hay, M J McGarccy, G R Stark, H С Thomas Expression of the terminal protein of hepatitis В virus is associated with failure to respond to interferon therapy Hepatology 17 (1993) 757-762 Garcia, G , С 1 Smith, J I Weissberg, M Eisenberg, J Bis-sett, P V Nair, В Mastre, S Rosno, D Roskamp, К Watre-man, RB Pollard, M J Tong, В W Brown, W S Robinson, P В Gregory, Th С Mengan Ade-nin arabmosid mo-nophosphate (vidarabme phosphate), in combination with human leukocyte interferon in the treatment of chronic hepatitis B) Ann intern Med 107 (1987) 278-285 Heijtink, R A , P Smal, FJ ten Kate, J Kruming and S W Schalm Detection of HBV-DNA in liver biopsy and serum its significance in the selection of hepatitis В patients for antiviral therapy Antiviral Res 7(1987)329-340 Hoofnagle, J H , M Peters, К D Mullen, D В Jones, V Rustgi, A Di Bisceglie, С Hallahan, Y Park, С Meschievitz and E A Jones Randomized, controlled tnal ofrecombmant human a-mterferon in patients with chronic hepatitis В Gastroenterology 95 (1988) 1318 Hoofnagle, J H Innovative therapies for chronic hepatitis В In Meyer zum Buschenfelde, К H , Hoofnagle, JH,M Manns (eds) Immunology and Liver Kluwer Academic Publishers, Dordrecht 1993 (p 120) Hoofnagle, J H , A M Di Bisceglie, H G Waggoner, Y Park Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis В Gastroenterology 104 (1993) 1116-1121 Janssen, H L A , S W Schalm, L Berk, R A de Man, R A Heijtink Repeated courses of alpha-mterferon for treatment of chronic hepatitis type В J Hepatol 1993 (Suppl 3) S47-S51 Kakumu, S , A Fuji, К Yoshioka, H Tahara, Y Hirofuji, К Murase, T Aoi Pilot study of recombinant human interleu-kin 2 for chronic type В hepatitis Hepatology 8 (1988) 487-492 Katkov, WN,J L Dienstag Prevention and therapy of chronic viral hepatitis Semin Liver Dis 11(1991)165-174 Korenmann, J , В Baker, J Waggoner, J E Everhart, A M Di Bisceglie, J H Hoofnagle Long-term remission of chronic hepatitis В after alpha-interferon therapy Ann intern Med 114 (1991) 629-634 Lai,Ch L ,A S F Lok,H J Lm,P С Wu, E К Yeoh, С Y Yeung Placebo-controlled tnal ofrecombmant az-interferon in Chinese HBsAg-carner children Lancet 1987/1, 877 Idenheim, J , F Yao, M С Martin, P В Gregory, С Mangels, G Garcia Survival m chronic hepatitis В A 15-year follow-up Hepatology 18 (1993) 251 (abstract) Lam, К С, С L Lai, С Trepro, P С Wu Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis New Engl J Med 304 (1981) 380-386 Lok, A S F , P С Wu, С L Lai, E К Y Leung Long-term follow-up in a randomised controlled trial of recombinant A-mterferon m Chinese patients with chronic hepatitis В infection Lancet 1988/11, 298-302 Lok, A S F , С L Lai, H T Chung, J Y N Lau, В К Y Leung, L S К Wong Morbidity and mortality from chronic hepatitis В virus infection in family members of patients with malignant and nonmalignant hepatitis В virus-related chronic liver diseases Hepatology 13 (1991) 834-837 Lok, A S FtO С К Ma, J N Lau Interferon alfa therapy in patients with chronic hepatitis В virus infection Effects on hepatitis В virus DNA in the liver Gastroenterology 100 (1991) 756-761 Mutchnick, M G , H D Appelman, H T Chung, E Aragona, T P Gupta, G D Cummings, J G Waggoner, J J Hoofnagle, D A Shafntz Thymosin treatment of chronic hepatitis В A PI ace bo-con trolled pilot trial Hepatology 14 (1991) 409-415 Nair, PV,MJTong, D Stevenson, D Roskamp, С Boone Effects of short-term, high-dose prednisone treatment of patients with HBsAg positive chronic active hepatitis Liver 5 (1985) 8-12 Nevens, F , P Goubau, P van Eyken, JDesmyter, J Desmet, V Fevery Treatment of decompensated viral hepatitis B-induced cirrhosis with low doses of interferon alpha Liver 13 (1993) 15-19 Pastore, G,T Santantonio, M Milella, L Monno, R Mo-schetta, L Pollice Anti-HBe-positive chronic hepatitis В with HBV-DN A in the serum response to a 6-month course of lymphoblastoid interferon J Hepatol 14 (1992) 221-325 Pernllo, R P Interferon-therapie for chronic type B, hepatitis the promise comes of age Gastroenterology 96 (1989) 532-536 Pernllo, R P , F G Regenstein, M G Peters, К DeSchryver-Kecskemeti, С JBodicky, С R Campbell, M С Kuhns Prednisone withdrawl followed by recombinant alpha interfe-ron in the treatment of chronic type В hepatitis Ann intern Med 108(1988)95-100 Pernllo, R P Interferon in the management of chronic hepatitis В Dig Disc Sci 38 (1993) 577-593 Pernllo, R P Antiviral therapy of chronic hepatitis В past, present, and future J Hepatol 17 (Suppl 3)1993 S56-S63 Poitnne, A , S Chousterman, M Chousterman, S Naveau, M N ThangandJ Chaput Lack of in vivo activation of the interferon system in HBsAg-positive chronic active hepatitis Hepatology5 (1985) 171-174 Renault, P F , J H Hoofnagle Side effects of alpha interferon Semin Liver Dis 9 (1989) 273-277 Ruiz-Moreno, M Chronic hepatitis В in children Natural history and treatment J Hepatol 17 (Suppl 3)1993 S64-S66 Ruiz-Moreno, M , M H Rua, |